Clinical Use of Antiviral Drugs Flashcards
HERPES VIRUS:
What are the 4 types?
——————–
Aciclovir (ACV):
What is it used for?
What does it do?
→ What are the steps it takes to do this?
→ Why does it only kill the viral DNA?
What is Valaciclovir?
→ What is it used for?
——————–
Ganciclovir:
What is it used for?
What does it do? How does it do it?
What is Valaganciclovir?
→ What is it used for?
——————–
Foscarnet:
What is it used for?
What does it do?
Who is it not used in? Why? When can it only be used?
Cidofovir:
What is it used for? How does it differ from Foscarnet?
Resistance:
What are the 2 ways Herpes virus can develop resistance?
→ In who does it rarely happen?
- • Herpes Simplex (HSV) - Cold sores, Genital ulcers
• Varicella Zoster (VZV) - Chickenpox, Shingles
• Cytomegalovirus (CMV)
• Epstein-Barr (EBV) - Infectious mononucleosis (Glandular fever)
——————– - HSV treatment, ZSV treatment and prophylaxis, and CMV/EBV prophylaxis
- Inhibits Viral DNA synthesis
→ • ACV phosphorylated by a HSV Thymidine Kinase (TK) and a cellular TK into ACV Triphosphate
• ACV Triphosphate competes with dGTP to bind to growing DNA - Once it binds, it stops any further growth = Cell death
→ ACV Triphosphate has more affinity for the viral DNA polymerase compared to the cell’s DNA polymerase = Selective Toxicity - Prodrug of Aciclovir (Valine ester attached)
→ VSV in Immunocompromised patients or CMV
prophylaxis in transplant patients
——————– - CMV - Treatment of reactivated infection after organ transplant, Congenital infection in a Newborn, and Prophylaxis after organ transplant
- Inhibits Viral DNA synthesis by doing the same thing as Aciclovir
- Prodrug of Ganciclovir (Valine ester attached)
→ Treatment and prophylaxis of CMV
——————– - CMV infection in Immunocompromised patients
- Inhibits Viral DNA synthesis
- Renal Transplant patients with CMV reactivation due to its Nephrotoxicity - Only used if there’s Ganciclovir resistance
- CMV, but is much more Nephrotoxic than Foscarnet
- Inhibits Viral DNA synthesis
- Thymidine Kinase mutants - Drugs that don’t need to be phosphorylated are still effective e.g. Foscarnet, Cidofovir
- DNA Polymerase mutants - All drugs become less effective
→ Immunocompetent patients
- DNA Polymerase mutants - All drugs become less effective
- Thymidine Kinase mutants - Drugs that don’t need to be phosphorylated are still effective e.g. Foscarnet, Cidofovir
INFLUENZA:
What does Zanamivir and Oseltamivir do? How?
How does Amantadine work?
Why does this virus become resistant so quickly?
- Inhibits virus release from infected cells by inhibiting Neuraminidase
- Inhibits virus uncoating by blocking the M2 protein when inside cells and the assembly of Haemagglutinin
- Only needs 1 amino acid change to become resistant
VIRAL HEPATITIS:
What does Chronic infection of Hep B and C lead to?
What can be given for treatment of Hep B?
→ Does this cure the patient?
What can be given for treatment of Hep C?
→ Does this cure the patient?
- Cirrhosis and Liver Cancer (Hepatocellular Carcinoma)
- Lamivudine, Tenofovir, Entecavir, Adefovir - Used by itself or in combination
→ Not curative but reduces risk of cirrhosis and cancer - Pegylated Interferon + Ribavirin, Sofosbuvir + Velpatsavir
→ Curable in many patients
HIV:
What are the steps of its infection?
What is used to reduce the risk of resistance? Why is this used?
What are the different Anti-retrovirals?
- • GP120 binds to CD4 receptor and CCR5 coreceptor for Penetration and Uncoating
• RNA then reverse transcribed into DNA = Production of viral proteins - Combination therapy as it evolves very quickly
- Reverse Transcriptase Inhibitors, Protease Inhibitors, CCR5 Inhibitors and Integrase Inhibitors - All combined into 1 pill